Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective - Concepedia

Concepedia

Publication | Open Access

Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective

DOI Full Paper Access

16

Citations

18

References

2022

Year

Andrea Carta, Maria Del Zompo, Anna Meloni, Francesco Molà, Pasquale Paribello, Federica Pinna, Marco Pinna, Claudia Pisanu, Mirko Manchia, Alessio Squassina,

Clinical Drug Investigation

References

	Year	Citations

Page 1